John Cairns

Professor of Health Economics

London School of Hygiene & Tropical Medicine

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

John Cairns is a Professor of Health Economics at the London School of Hygiene and Tropical Medicine in the United Kingdom. His research focuses on the economic aspects of healthcare, particularly in relation to cancer treatment and rare diseases. Recent articles authored by Professor Cairns include studies on the quality of life after breast cancer, cost-effectiveness analyses in multiple myeloma treatment, and the role of real-world data in health technology assessments.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (3)

Stuart Wright

The University of Manchester

UNITED KINGDOM

View details

Melissa Ooi

Assistant Professor of Medicine

National University of Singapore (NUS)

SINGAPORE

View details

Jack Blumenau

Professor of Political Science

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

John Cairns

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Long-term quality of life and quality adjusted life years after breast cancer: Impact of detection mode, tumor characteristics and treatment

Using automated text classification to explore uncertainty in NICE appraisals for drugs for rare diseases

Modeling First-Line Daratumumab Use for Newly Diagnosed, Transplant-Ineligible, Multiple Myeloma: A Cost-Effectiveness and Risk Analysis for Healthcare Payers

Exploring patient and clinician views of the risk and benefits of emerging therapies for the treatment of haemophilia: a qualitative study

Cross-sectional analysis of use of real-world data in single technology appraisals of oncological medicine by the National Institute for Health and Care Excellence in 2011–2021

Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy

“Don’t Think Twice, It’s All Right”: Using Additional Data to Reduce Uncertainty Regarding Oncologic Drugs Provided Through Managed Access Agreements in England

Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy

Discrete choice experiments: An overview of experience to date in haemophilia

Protocol for data extraction: how real-world data have been used in the National Institute for Health and Care Excellence appraisals of cancer therapy

How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review

A Mobile Phone–Based Support Intervention to Increase Use of Postabortion Family Planning in Cambodia: Cost-Effectiveness Evaluation

Collaborators (3)

Stuart Wright

Melissa Ooi

Jack Blumenau

Make your next move.